Hutch News

Hutch News

Stories tagged 'immunotherapy'

Squelching ovarian cancer: the not-so-silent killer

The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease

Sept. 17, 2018 | By Diane Mapes / Fred Hutch News Service

September is Ovarian Cancer Awareness Month, but Fred Hutch researchers are working year-round to find ways to detect the disease early and shut it down for good. Read on for a handful of ovarian cancer research highlights.

View story >


Want to make better T-cell therapies? First, figure out how they work.

New study maps out activities, effects of widely used components in cellular immunotherapies

Aug. 21, 2018 | By Susan Keown / Fred Hutch News Service

This work "gives us a direction" to create better, next-gen versions of this type of cancer immunotherapy, called CAR T-cell therapy, the researchers said.

View story >


Drs. Siddhartha Mukherjee and Gary Gilliland in conversation

Watch: Author and physician-scientist discusses the next chapters in cancer research — and his book ‘Emperor of all Maladies’ — with Hutch President and Director

Aug. 2, 2018 | Video by Robert Hood / Fred Hutch News Service

A conversation on recent strides in cancer research and care, empowering young scientists, communicating advances, and new chapters for "Emperor of All Maladies."

View story >


Nanoparticles open doors to cancer-fighting CAR T cells

Tiny liposome-based drug carriers make tumors more vulnerable to targeted immunotherapy

July 2, 2018 | By Sabrina Richards / Fred Hutch News Service

Scientists at Fred Hutchinson Cancer Research Center have developed a cheap way to make cancers temporarily vulnerable to immune attack using liposome-based nanoparticles to carry immune-boosting drugs deep into tumors.

View story >


New guide helps clinicians navigate immunotherapy revolution in Merkel cell carcinoma

‘Real-world’ review accompanies new clinical care guidelines in rare skin cancer

June 28, 2018 | By Susan Keown / Fred Hutch News Service

Fred Hutchinson Cancer Research Center researchers have published a new guide to help clinicians navigate a recent revolution in care for advanced Merkel cell carcinoma, a rare and deadly skin cancer.

View story >


His immune system eradicated his melanoma. Could other patients’ bodies be taught to do the same thing?

How one man’s T cells are guiding the development of next-gen immunotherapies

June 19, 2018 | by Susan Keown / Fred Hutch News Service

Chris Pope's immune system eradicated his stage 4 melanoma on an immunotherapy clinical trial. Is it possible to genetically reprogram other patients' to do the same thing?

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.